Regenxbio (RGNX) Receivables (2016 - 2025)
Historic Receivables for Regenxbio (RGNX) over the last 12 years, with Q3 2025 value amounting to $28.2 million.
- Regenxbio's Receivables rose 1622.78% to $28.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.2 million, marking a year-over-year increase of 1622.78%. This contributed to the annual value of $21.2 million for FY2024, which is 2956.31% down from last year.
- Latest data reveals that Regenxbio reported Receivables of $28.2 million as of Q3 2025, which was up 1622.78% from $21.8 million recorded in Q2 2025.
- Regenxbio's Receivables' 5-year high stood at $73.0 million during Q2 2022, with a 5-year trough of $19.4 million in Q1 2025.
- In the last 5 years, Regenxbio's Receivables had a median value of $30.2 million in 2022 and averaged $38.0 million.
- In the last 5 years, Regenxbio's Receivables tumbled by 7787.99% in 2021 and then skyrocketed by 5824.74% in 2022.
- Quarter analysis of 5 years shows Regenxbio's Receivables stood at $35.8 million in 2021, then surged by 58.25% to $56.6 million in 2022, then plummeted by 46.87% to $30.1 million in 2023, then dropped by 29.56% to $21.2 million in 2024, then soared by 33.13% to $28.2 million in 2025.
- Its Receivables was $28.2 million in Q3 2025, compared to $21.8 million in Q2 2025 and $19.4 million in Q1 2025.